Literature DB >> 33587233

Harrington rods for periacetabular pathological lesion: is it an option?

Yahya Elhassan1, John Guerin2, James Harty2.   

Abstract

Advancement in cancer treatment has prolonged the survival of cancer patients; as a result, there are an increased number of patients with bone metastases and pathological fractures referred to orthopaedic surgeons for surgical intervention for a better quality of life. Metastasis around the hip joint can be painful and intervene with patients' daily activity, and reconstruction of the hip joint with periacetabular metastasis is complex and challenging especially longer cancer survivals might out-live their fixation. Several acetabular reconstruction techniques and implants have been described to overcome this problem; acetabular reconstruction and total hip arthroplasty still remains the standard surgical treatment, to relief pain and to improve function and quality of life. Harrington reconstruction of periacetabular metastatic disease combined with hip arthroplasty is one of the options that can address this clinical scenario safely; it is reproducible and cost-effective. In this review, we present case series of patients treated in our institution using Harrington rod technique for acetabular pathological lesions with good outcome.
© 2021. Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Acetabulum; Harrington rods; Metastasis

Mesh:

Year:  2021        PMID: 33587233     DOI: 10.1007/s11845-021-02538-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  2 in total

1.  Reconstruction of advanced periacetabular metastatic lesions with modified Harrington procedure.

Authors:  Bülent Erol; Ahmet Nadir Aydemir; Tolga Onay; Mert Osman Topkar
Journal:  Acta Orthop Traumatol Turc       Date:  2016       Impact factor: 1.511

2.  Reconstruction of metastatic acetabular defects using a modified Harrington procedure.

Authors:  Panagiotis Tsagozis; Rikard Wedin; Otte Brosjö; Henrik Bauer
Journal:  Acta Orthop       Date:  2015-07-28       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.